Differential effects of Vpr on single-cycle and spreading HIV-1 infections in CD4+ T-cells and dendritic cells

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  de Silva, Suresh ^a   Planelles, Vicente ^b   Wu, Li ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VPR PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL CYCLE; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; REVERSE TRANSCRIPTION; TARGET CELL; VIRION; VIRUS REPLICATION;

CARRIER PROTEINS; CELL LINE; CELLS, CULTURED; DENDRITIC CELLS; DNA, VIRAL; GENE SILENCING; GENES, GAG; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; PROVIRUSES; RNA INTERFERENCE; RNA, MESSENGER; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84860534449     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035385     Document Type: Article

References (53)

1. Le Rouzic E, Benichou S, (2005) The Vpr protein from HIV-1: distinct roles along the viral life cycle. Retrovirology 2: 11.
2. Andersen JL, Planelles V, (2005) The role of Vpr in HIV-1 pathogenesis. Curr HIV Res 3: 43-51.
3. Majumder B, Venkatachari NJ, Srinivasan A, Ayyavoo V, (2009) HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). Curr HIV Res 7: 169-177.
4. Schwartz S, Felber BK, Pavlakis GN, (1991) Expression of human immunodeficiency virus type 1 vif and vpr mRNAs is Rev-dependent and regulated by splicing. Virology 183: 677-686.
5. Paxton W, Connor RI, Landau NR, (1993) Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. J Virol 67: 7229-7237.
6. Lama J, Planelles V, (2007) Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology 4: 52.
7. Planelles V, Benichou S, (2009) Vpr and its interactions with cellular proteins. Current Topics in Microbiology and Immunology 339: 177-200.
8. Rogel ME, Wu LI, Emerman M, (1995) The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. Journal of Virology 69: 882-888.
9. Gummuluru S, Emerman M, (1999) Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines. J Virol 73: 5422-5430.
10. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, et al. (1998) HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nature Medicine 4: 65-71.
11. Agostini I, Navarro JM, Rey F, Bouhamdan M, Spire B, et al. (1996) The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB. J Mol Biol 261: 599-606.
12. Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, et al. (2001) Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J Virol 75: 3791-3801.
13. Arokium H, Kamata M, Chen I, (2009) Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J Virol 83: 11283-11297.
14. Mansky LM, Preveral S, Selig L, Benarous R, Benichou S, (2000) The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J Virol 74: 7039-7047.
15. Majumder B, Janket ML, Schafer EA, Schaubert K, Huang XL, et al. (2005) Human immunodeficiency virus type 1 Vpr impairs dendritic cell maturation and T-cell activation: implications for viral immune escape. J Virol 79: 7990-8003.
16. Ayyavoo V, Mahboubi A, Mahalingam S, Ramalingam R, Kudchodkar S, et al. (1997) HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nature Medicine 3: 1117-1123.
17. Dehart JL, Planelles V, (2008) Human immunodeficiency virus type 1 Vpr links proteasomal degradation and checkpoint activation. J Virol 82: 1066-1072.
18. DeHart JL, Zimmerman ES, Ardon O, Monteiro-Filho CM, Arganaraz ER, et al, (2007) HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system. Virol J 4: 57.
19. Belzile JP, Duisit G, Rougeau N, Mercier J, Finzi A, et al. (2007) HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase. PLoS Pathog 3: e85.
20. Hrecka K, Gierszewska M, Srivastava S, Kozaczkiewicz L, Swanson SK, et al. (2007) Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc Natl Acad Sci U S A 104: 11778-11783.
21. Connor RI, Chen BK, Choe S, Landau NR, (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206: 935-944.
22. Balliet JW, Kolson DL, Eiger G, Kim FM, McGann KA, et al. (1994) Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology 200: 623-631.
23. Heinzinger NK, Bukinsky MI, Haggerty SA, Ragland AM, Kewalramani V, et al, (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sci U S A 91: 7311-7315.
24. Vodicka MA, Koepp DM, Silver PA, Emerman M, (1998) HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev 12: 175-185.
25. Subbramanian RA, Kessous-Elbaz A, Lodge R, Forget J, Yao XJ, et al. (1998) Human immunodeficiency virus type 1 Vpr is a positive regulator of viral transcription and infectivity in primary human macrophages. J Exp Med 187: 1103-1111.
26. Dedera D, Hu W, Vander Heyden N, Ratner L, (1989) Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J Virol 63: 3205-3208.
27. Yamashita M, Perez O, Hope TJ, Emerman M, (2007) Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathogens 3: 1502-1510.
28. Yamashita M, Emerman M, (2009) Cellular restriction targeting viral capsids perturbs human immunodeficiency virus type 1 infection of nondividing cells. Journal of Virology 83: 9835-9843.
29. Gallay P, Hope T, Chin D, Trono D, (1997) HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci U S A 94: 9825-9830.
30. Riviere L, Darlix JL, Cimarelli A, (2010) Analysis of the viral elements required in the nuclear import of HIV-1 DNA. J Virol 84: 729-739.
31. Ao Z, Yao X, Cohen EA, (2004) Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system. J Virol 78: 3170-3177.
32. Yamashita M, Emerman M, (2005) The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathogens 1: e18.
33. Freed EO, Englund G, Martin MA, (1995) Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69: 3949-3954.
34. Wu L, Martin TD, Vazeux R, Unutmaz D, KewalRamani VN, (2002) Functional evaluation of DC-SIGN monoclonal antibodies reveals DC-SIGN interactions with ICAM-3 do not promote human immunodeficiency virus type 1 transmission. J Virol 76: 5905-5914.
35. Janas AM, Wu L, (2009) HIV-1 interactions with cells: from viral binding to cell-cell transmission. Curr Protoc Cell Biol Chapter 26: Unit 26 25.
36. Cecilia D, KewalRamani VN, O'Leary J, Volsky B, Nyambi P, et al. (1998) Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 72: 6988-6996.
37. Planelles V, Bachelerie F, Jowett JB, Haislip A, Xie Y, et al. (1995) Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J Virol 69: 5883-5889.
38. Dong C, Janas AM, Wang JH, Olson WJ, Wu L, (2007) Characterization of human immunodeficiency virus type 1 replication in immature and mature dendritic cells reveals dissociable cis- and trans-infection. J Virol 81: 11352-11362.
39. Pertel T, Reinhard C, Luban J, (2011) Vpx rescues HIV-1 transduction of dendritic cells from the antiviral state established by type 1 interferon. Retrovirology 8: 49.
40. Wang JH, Janas AM, Olson WJ, KewalRamani VN, Wu L, (2007) CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1. J Virol 81: 2497-2507.
41. Smed-Sorensen A, Lore K, Vasudevan J, Louder MK, Andersson J, et al. (2005) Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells. J Virol 79: 8861-8869.
42. Wang JH, Janas AM, Olson WJ, Wu L, (2007) Functionally distinct transmission of human immunodeficiency virus type 1 mediated by immature and mature dendritic cells. J Virol 81: 8933-8943.
43. Coleman CM, Spearman P, Wu L, (2011) Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology 8: 26.
44. Coleman CM, Wu L, (2009) HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 6: 51.
45. Rey F, BouHamdan M, Navarro JM, Agostini I, Willetts K, et al. (1998) A role for human immunodeficiency virus type 1 Vpr during infection of peripheral blood mononuclear cells. J Gen Virol 79 (Pt 5): 1083-1087.
46. Ayinde D, Maudet C, Transy C, Margottin-Goguet F, (2010) Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr? Retrovirology 7: 35.
47. St Gelais C, Wu L, (2011) SAMHD1: a new insight into HIV-1 restriction in myeloid cells. Retrovirology 8: 55.
48. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, et al. (2011) SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474: 654-657.
49. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, et al. (2011) Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474: 658-661.
50. Gramberg T, Sunseri N, Landau NR, (2010) Evidence for an activation domain at the amino terminus of simian immunodeficiency virus Vpx. Journal of Virology 84: 1387-1396.
51. Berger G, Durand S, Fargier G, Nguyen XN, Cordeil S, et al. (2011) APOBEC3A Is a Specific Inhibitor of the Early Phases of HIV-1 Infection in Myeloid Cells. PLoS Pathog 7: e1002221.
52. Planelles V, (2011) Restricted access to myeloid cells explained. Viruses 3: 1624-1633.
53. Wu L, Martin TD, Carrington M, KewalRamani VN, (2004) Raji B cells, misidentified as THP-1 cells, stimulate DC-SIGN-mediated HIV transmission. Virology 318: 17-23.